Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors

被引：11
|
作者：
Liu, Qing [1 ,2 ,3 ]
Cai, Xiaoqing [2 ,3 ]
Yang, Dehua [2 ,3 ]
Chen, Yi [4 ]
Wang, Yafang [4 ]
Shao, Liming [1 ]
Wang, Ming-Wei [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[3] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2017年 / 25卷 / 17期
基金：
中国国家自然科学基金;
关键词：
Methyltransferase inhibitor; Cycloalkyl substituted analogue; Natural product; Sinefungin; METHYLTRANSFERASE G9A; GLP; METHYLATION; MECHANISM;
D O I：
10.1016/j.bmc.2017.06.032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of cycloalkyl substituted analogues of the natural product sinefungin lacking the amino-acid moiety was designed and synthesized. Two stereoisomers (6-R and 6-S) were separated and their bioactivities examined against EHMT1/2. Of which, compound 14d showed an inhibitory activity against EHMT1/2 (88.9%, IC50 = 21.8 mu M for EHMT1 and 77.6%, IC50 = 39.6 mu M for EHMT2, respectively) similar to that of sinefungin (100.0%, IC50 = 28.4 mu M for EHMT1 and 79.5%, IC50 = 30.1 mu M for EHMT2, respectively). Further studies against other methyltransferases such as PRMT1 showed no activity except that 12d displayed about 20% inhibition. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4579 / 4594
页数：16
相关论文
共 50 条
  • [31] VASCULAR ENDOTHELIAL GROWTH FACTOR A REGULATES BLOOD CELL DEVELOPMENT THROUGH EHMT1
    Lu, X.
    Fang, Y.
    Zhang, Y.
    Zheng, Y.
    Tan, Y.
    CYTOKINE, 2016, 87 : 139 - 140
  • [32] The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy
    Thienpont, Bernard
    Aronsen, Jan Magnus
    Robinson, Emma Louise
    Okkenhaug, Hanneke
    Loche, Elena
    Ferrini, Arianna
    Brien, Patrick
    Alkass, Kanar
    Tomasso, Antonio
    Agrawal, Asmita
    Bergmann, Olaf
    Sjaastad, Ivar
    Reik, Wolf
    Roderick, Hywel Llewelyn
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01): : 335 - 348
  • [33] Kleefstra-variant syndrome with heterozygous mutations in EHMT1 and KCNQ2 genes: a case report
    Marchese, Giovanna
    Rizzo, Francesca
    Guacci, Anna
    Weisz, Alessandro
    Coppola, Giangennaro
    NEUROLOGICAL SCIENCES, 2016, 37 (05) : 829 - 831
  • [34] Histone Methylation by the Kleefstra Syndrome Protein EHMT1 Mediates Homeostatic Synaptic Scaling
    Benevento, Marco
    Iacono, Giovanni
    Selten, Martijn
    Ba, Wei
    Oudakker, Astrid
    Frega, Monica
    Keller, Jason
    Mancini, Roberta
    Lewerissa, Elly
    Kleefstra, Tjitske
    Stunnenberg, Henk G.
    Zhou, Huiqing
    van Bokhoven, Hans
    Kasri, Nael Nadif
    NEURON, 2016, 91 (02) : 341 - 355
  • [35] Kleefstra-variant syndrome with heterozygous mutations in EHMT1 and KCNQ2 genes: a case report
    Giovanna Marchese
    Francesca Rizzo
    Anna Guacci
    Alessandro Weisz
    Giangennaro Coppola
    Neurological Sciences, 2016, 37 : 829 - 831
  • [36] Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
    Zachary L. Watson
    Tomomi M. Yamamoto
    Alexandra McMellen
    Hyunmin Kim
    Connor J. Hughes
    Lindsay J. Wheeler
    Miriam D. Post
    Kian Behbakht
    Benjamin G. Bitler
    Clinical Epigenetics, 2019, 11
  • [37] Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
    Watson, Zachary L.
    Yamamoto, Tomomi M.
    McMellen, Alexandra
    Kim, Hyunmin
    Hughes, Connor J.
    Wheeler, Lindsay J.
    Post, Miriam D.
    Behbakht, Kian
    Bitler, Benjamin G.
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [38] Dual PARP and EHMT1/2 inhibition induces an interferon response and anti-tumor immunity in ovarian cancer
    Nguyen, Lily
    Watson, Zachary L.
    Woodruff, Elizabeth R.
    Jordan, Kimberly R.
    Chuong, Edward
    Bitler, Benjamin G.
    CANCER RESEARCH, 2024, 84 (05)
  • [39] Proper ATM activation mediated by lysine methyltransferases EHMT1/2 upon DNA damage: relevance to senescence and cancer
    Watanabe, Sugiko
    Iimori, Makoto
    Kitao, Hiroyuki
    Maehara, Yoshihiko
    Hara, Eiji
    CANCER SCIENCE, 2018, 109 : 190 - 190
  • [40] Constitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma
    Cheung, Hannah C.
    Yatsenko, Svetlana A.
    Kadapakkam, Meena
    Legay, Helene
    Su, Jack
    Lupski, James R.
    Plon, Sharon E.
    PEDIATRIC BLOOD & CANCER, 2012, 58 (05) : 801 - 805
12345